Bone Biologics (BBLGW) Return on Capital Employed (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Return on Capital Employed for 2 consecutive years, with 1.74% as the latest value for Q3 2017.
Bone Biologics (BBLGW) has disclosed Return on Capital Employed for 2 consecutive years, with 1.74% as the latest value for Q3 2017.